Corporate
Description
  • Value proposition

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP


    in vitro diagnostics, infectious diseases, reagents, automated instruments, medical analysis, cosmetics, pharmaceutical, industries, healthcare associated infections, molecular biology, microbiology, immunoassays, antimicrobial stewardship, rapid diagnostics, food safety, veterinary diagnostics, blood bank, and sepsis

  • Original language

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP

Entity interactions BETA
Entity TypeTweets Articles
MEDES - Institute for Space Medicine and Physiology MEDES - Institute for Space Medicine and Physiology
deeptech, healthtech, Aviation and Aerospace Component Manufacturing
Other

16 Jan 2018


i2S Innovative Imaging Solutions i2S Innovative Imaging Solutions
it services, IT Services and IT Consulting
Not capitalistic
Partnership
Event

21 Mar 2016


Circet Circet
Telecommunications
Not capitalistic
Not partnership
Event

27 Jul 2021


SKF Group SKF Group
it services, Industrial Machinery Manufacturing
Not capitalistic
Not partnership
Event

30 May 2018


AMIES (Agence Maths-Entreprises) AMIES (Agence Maths-Entreprises)
deeptech, IT Services and IT Consulting
Other

13 Dec 2017


BDM BDM
Software Development
Other

12 May 2021


Fondation Mérieux Fondation Mérieux
healthtech, Non-profit Organizations
Other

6 Sep 2021

7 Nov 2023



HANDISHARE HANDISHARE
hrtech, IT Services and IT Consulting
Not capitalistic
Not partnership
Event

7 Oct 2016


Aract Auvergne-Rhône-Alpes Aract Auvergne-Rhône-Alpes
Business Consulting and Services
Other

20 Sep 2018


Fromont Briens Fromont Briens
Law Practice, legaltech
Not capitalistic
Not partnership
Event

23 Mar 2021


Radars
Loading...